0      0


AM21-44: Assessment and Treatment of COVID-19 Coagulopathy


Oct 19, 2021 3:45pm ‐ Oct 19, 2021 4:45pm



Credits: None available.

Description


This program will describe what is currently known about the unique thrombo-inflammatory coagulopathic response associated with SARS-CoV2 infection, how it is uniquely different from other thrombotic disorders, and how current testing strategies including the use of thromboelastography/rotational thromboelastometry can be used to assess or to understand COVID-19 associated coagulopathy. Finally. anticoagulant strategies to prevent and treat COVID-19 associated coagulopathy will be evaluated, along with discussion of the latest clinical treatment trial results.

Moderator(s):

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.